Gabriela Monserrat Mimendi-Aguilar, Michael Dean, Silvia Esperanza Flore-Martínez, Alejandra Guadalupe García-Zapien, José Sánchez-Corona, María Fernanda Romero-Morán, Martha Arisbeth Villanueva-Pérez, Erick Sierra-Díaz, Salvador Sánchez-Benavides, Ingrid Patricia Dávalos-Rodríguez, Jesús Alejandro Juárez-Ozuna, Mónica Alejandra Rosales-Reynoso, Maria Cristina Morán Moguel
{"title":"Variants of the ABCG2 gene in Mexican mestizo patients with prostate cancer.","authors":"Gabriela Monserrat Mimendi-Aguilar, Michael Dean, Silvia Esperanza Flore-Martínez, Alejandra Guadalupe García-Zapien, José Sánchez-Corona, María Fernanda Romero-Morán, Martha Arisbeth Villanueva-Pérez, Erick Sierra-Díaz, Salvador Sánchez-Benavides, Ingrid Patricia Dávalos-Rodríguez, Jesús Alejandro Juárez-Ozuna, Mónica Alejandra Rosales-Reynoso, Maria Cristina Morán Moguel","doi":"10.14715/cmb/2024.70.12.25","DOIUrl":null,"url":null,"abstract":"<p><p>ABCG2 transporter protein is one of several markers of prostate cancer stem cells (PCSCs). Gene variants of ABCG2 could affect protein expression, function, or both. The aim of this study was to identify the genetic variability of the ABCG2 gene in Mexican patients with prostate cancer. Genomic DNA (gDNA) was obtained from peripheral blood samples of 32 Mexican patients with prostate cancer. ABCG2 gene was sequenced. The electropherograms were analyzed using mutation surveyor DNA mutation analysis software (Softgenetics). The ABCG2 gene sequence revealed the presence of 22 variants: 19 previously described and three previously undescribed gene variants as part of the ABCG2 gene variability in the Mexican mestizo population (R263K G>A, R378K G>A, and Q531Q G>A). No ABCG2 variant was identified in one patient, but 1 to 12 variants were identified in the remaining 31 patients. The transition G>A was the most frequently found substitution. The largest number of ABCG2 variants was located in exon 9, and at least one of them was present in 28 of the 31 subjects in the Mexican population. The individual genetic variability of ABCG2 should be analyzed, considering its possible usefulness in personalized medicine in patients with prostate cancer.</p>","PeriodicalId":9802,"journal":{"name":"Cellular and molecular biology","volume":"70 12","pages":"180-187"},"PeriodicalIF":1.5000,"publicationDate":"2025-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular and molecular biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.14715/cmb/2024.70.12.25","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
ABCG2 transporter protein is one of several markers of prostate cancer stem cells (PCSCs). Gene variants of ABCG2 could affect protein expression, function, or both. The aim of this study was to identify the genetic variability of the ABCG2 gene in Mexican patients with prostate cancer. Genomic DNA (gDNA) was obtained from peripheral blood samples of 32 Mexican patients with prostate cancer. ABCG2 gene was sequenced. The electropherograms were analyzed using mutation surveyor DNA mutation analysis software (Softgenetics). The ABCG2 gene sequence revealed the presence of 22 variants: 19 previously described and three previously undescribed gene variants as part of the ABCG2 gene variability in the Mexican mestizo population (R263K G>A, R378K G>A, and Q531Q G>A). No ABCG2 variant was identified in one patient, but 1 to 12 variants were identified in the remaining 31 patients. The transition G>A was the most frequently found substitution. The largest number of ABCG2 variants was located in exon 9, and at least one of them was present in 28 of the 31 subjects in the Mexican population. The individual genetic variability of ABCG2 should be analyzed, considering its possible usefulness in personalized medicine in patients with prostate cancer.
期刊介绍:
Cellular and Molecular Biology publishes original articles, reviews, short communications, methods, meta-analysis notes, letters to editor and comments in the interdisciplinary science of Cellular and Molecular Biology linking and integrating molecular biology, biophysics, biochemistry, enzymology, physiology and biotechnology in a dynamic cell and tissue biology environment, applied to human, animals, plants tissues as well to microbial and viral cells. The journal Cellular and Molecular Biology is therefore open to intense interdisciplinary exchanges in medical, dental, veterinary, pharmacological, botanical and biological researches for the demonstration of these multiple links.